LEADER 02441nam  2200721zu 450 
001 9910693954403321
005 20251017110052.0
035   $a(CKB)2670000000410512
035   $a(SSID)ssj0000622386
035   $a(PQKBManifestationID)11400721
035   $a(PQKBTitleCode)TC0000622386
035   $a(PQKBWorkID)10637290
035   $a(PQKB)20440370
035   $a(WaSeSS)Innodata00030705
035   $a(GPO)apn2005-011438
035   $a(OCoLC)60678525
035   $a(DNLM)1561831
035   $a(EXLCZ)992670000000410512
100   $a20160829d2005      uy 
101 0 $aeng
135   $aur|||||||||||
181   $ctxt
182   $cc
183   $acr
200 00$aPost-myocardial infarction depression
210 31$a[Place of publication not identified]$cAgency for Healthcare Research and Quality$d2005
215   $a1 online resource
225 0 $aEvidence report/technology assessment Post-myocardial infarction depression
300   $aBibliographic Level Mode of Issuance: Monograph
320   $aIncludes bibliographical references.
410  0$aEvidence report/technology assessment ;$vno. 123.
410  0$aAHRQ publication ;$vno. 05-E018-2.
606   $aMyocardial infarction$xComplications$xTreatment$xEvaluation
606   $aMyocardial infarction$xPsychosomatic aspects
606   $aDepression, Mental$xTreatment
606   $aMood Disorders
606   $aDisease
606   $aMental Disorders
606   $aDepressive Disorder
606   $aNeoplasms
606   $aMedicine$2HILCC
606   $aHealth & Biological Sciences$2HILCC
606   $aCardiovascular Diseases$2HILCC
615  0$aMyocardial infarction$xComplications$xTreatment$xEvaluation.
615  0$aMyocardial infarction$xPsychosomatic aspects.
615  0$aDepression, Mental$xTreatment.
615  2$aMood Disorders.
615  2$aDisease.
615  2$aMental Disorders.
615  2$aDepressive Disorder.
615  2$aNeoplasms.
615  7$aMedicine
615  7$aHealth & Biological Sciences
615  7$aCardiovascular Diseases
676   $a616.1/23706
702   $aBush$b David E.
712 02$aUnited States Agency for Healthcare Research and Quality
712 02$aJohns Hopkins University Evidence-based Practice Center
801  0$bPQKB
906   $aBOOK
912   $a9910693954403321
996   $aPost-myocardial infarction depression$93124921
997   $aUNINA